RO94155A2
|
|
Oral gel
|
RO92346A2
|
|
Topical preparation for treating peripheral arteriopathies
|
RO91976A2
|
|
Medicine with vitamins as moulded tablets
|
RO91513A2
|
|
Flu tablets
|
RO91724A2
|
|
Radioprotective lotion
|
RO88972A2
|
|
Phytoterapeutic adjuvant product in treatment of obesity
|
RO89461A2
|
|
Phytopharmaceutical product for the treatment of prostate disorders
|
RO89462A2
|
|
Phytopharmaceutical product for the treatment of parkinson disease
|
RO89075A2
|
|
Method of identifying and dosing alains from symphytumofficinal extracts l.
|
RO86993B1
|
|
Injectable nitroglycerine solution for administration in perfusion
|
RO88836A2
|
|
Procedure for obtaining pediatric used eritromicin comprimate
|
RO84079A2
|
|
Medicinal composition for topic treatment of benign mastopathy
|
RO86748A2
|
|
Method for quantitatively determining the caffeic acid-type polyphenol compounds in the cynara scolymus l. leaves
|
RO85947B1
|
|
10% potassium chloride solution for internal use
|
RO84890A2
|
|
Method for identifying and determining cephalotine and cephazoline purity
|
RO84556A3
|
|
Process for preparing silimarin
|
RO83511A2
|
|
Pharmaceutical product with sedative-hypnogenic action
|
RO83317A2
|
|
Medicinal product with expectorant antitussive activity and process for preparing the same
|
RO82841A2
|
|
Suspension with paracetamol
|
RO77161A2
|
|
Chemotherapy method for substitution for powder of penoxyacethic acid in penoximethylpeniciline acid and potassium salt
|